Health CanadaGeneral Alert

JAMP Digoxin tablets: One lot recalled due to possible oversized tablets which may pose overdose risk

Publicado: 31 de mayo de 2024ID de Retiro: 75604Categoría: Productos de ConsumoPaís: Canadá
Canada
Safety AlertHealth CanadaCanadaCanada

JAMP Digoxin tablets: One lot recalled due to possible oversized tablets which may pose overdose risk

Recalling Firm: Communications and Public Affairs Branch

🌐
Traducir AvisoTranslate notice text, hazard warnings, and descriptions into any supported language.

Motivo del Retiro / Peligro

Product safety

Descripción del Producto e Identificación

Return your JAMP Digoxin 0.0625 mg tablets to your pharmacy for replacement as soon as possible. Until you can return them, continue to take your JAMP Digoxin but do not take tablets that look oversized (see image, which shows an oversized tablet on the left and proper-sized tablet on the right). If you are unsure whether your product is affected, check with your pharmacy.Contact a health care professional immediately if you or someone you are caring for experience serious side effects.Contact JAMP Pharma Corporation by calling toll-free at 1-866-399-9091, extension 501, or by email at custjamp@jamppharma.com, if you have questions about this recall.Report any health product-related side effects or complaints to Health Canada.Additional information for health professionals: Health care professionals, such as pharmacists, should check bottles of JAMP Digoxin 0.0625 mg tablets before dispensing and report any unusual tablets to the company and to Health Canada.

Productos Afectados

JAMP Digoxin 0.0625 mg tablets (lot EG23DGX001, expiry 07-2025)

Additional Source Details

FieldValue
N I D75604
U R Lhttps://recalls-rappels.canada.ca/en/alert-recall/jamp-digoxin-tablets-one-lot-recalled-due-possible-oversized-tablets-which-may-pose
IssueProduct safety
TitleJAMP Digoxin tablets: One lot recalled due to possible oversized tablets which may pose overdose risk
ProductJAMP Digoxin 0.0625 mg tablets (lot EG23DGX001, expiry 07-2025)
Archived0
CategoryHealth products
Last updated2024-05-31
OrganizationCommunications and Public Affairs Branch
What you should doReturn your JAMP Digoxin 0.0625 mg tablets to your pharmacy for replacement as soon as possible. Until you can return them, continue to take your JAMP Digoxin but do not take tablets that look oversized (see image, which shows an oversized tablet on the left and proper-sized tablet on the right). If you are unsure whether your product is affected, check with your pharmacy.Contact a health care professional immediately if you or someone you are caring for experience serious side effects.Contact JAMP Pharma Corporation by calling toll-free at 1-866-399-9091, extension 501, or by email at custjamp@jamppharma.com, if you have questions about this recall.Report any health product-related side effects or complaints to Health Canada.Additional information for health professionals: Health care professionals, such as pharmacists, should check bottles of JAMP Digoxin 0.0625 mg tablets before dispensing and report any unusual tablets to the company and to Health Canada.

Consumer Action Protocol: What You Should Do Immediately

Safety Steps
1Verify Product Identifiers

Check the model number, serial number, and date stamp on the rating label on the back or underside of the product.

2Isolate & Discontinue Use

Immediately discontinue using the product. Unplug electrical items and keep juvenile items out of reach of children.

3Claim Free Statutory Remedy

Under statutory consumer protection rules, consumers are entitled to a full refund, certified replacement, or free repair kit without needing the original sales receipt.

4Report Adverse Incidents

If you suffered an injury, illness, or property damage from this product, file an official incident report with regulatory authorities (Health Canada).

Your Legal Rights as a Consumer

Recalls are legally binding corrective safety actions overseen by statutory government bodies. Recalling entities are legally prohibited from charging consumers for official safety remedies. If a retailer or dealership refuses your recall remedy, notify the issuing regulatory agency immediately.

Frequently Asked Questions About This Recall

FAQ Guide

Q1:What should I do immediately if I own or bought JAMP Digoxin tablets: One lot recalled due to possible oversized tablets which may pose overdose risk?

Immediately stop using the product and keep it out of reach of children. Disconnect power if electrical, and do not attempt makeshift home repairs.

Q2:Can I get a full refund or free repair for this recall?

Yes. Recalling manufacturers and retail merchants are required under consumer protection regulations to offer a statutory remedy—typically a full refund, certified repair kit, or replacement unit.

Q3:Do I need my original sales receipt to claim a remedy or refund?

In most recall cases, no receipt is required. Because safety recalls are matters of public health and statutory compliance, retailers and manufacturers routinely issue refunds, store credit, or replacement kits upon presentation of the affected product or lot code.

Q4:Where can I verify official information for this safety alert?

This safety alert is aggregated directly from official regulatory agency records (Health Canada). You can click the 'Official Agency Alert' link on this page to view the primary government notice and contact the manufacturer directly.

Revise otros productos en su hogar

Herramientas Gratuitas

Safety recalls are issued daily across foods, medications, vehicles, and electronics. Use our instant tools to check your home for active safety warnings:

Resumen

  • Empresa ResponsableCommunications and Public Affairs Branch
Recall Hazard Severity
Caution (Class III)
Alerta Oficial de la Agencia

📢 Compartir advertencia

Alert family and friends to keep them safe. Copy this quick alert message:

🚨 SAFETY ALERT: Communications and Public Affairs Branch - JAMP Digoxin tablets: One lot recalled due to possible oversized tablets which may pose overdose risk

Check if your household is affected:
https://therecallfile.com/es/recalls/jamp-digoxin-tablets-one-lot-recalled-due-to-possible-oversized-tablet/CANADA-75604
WhatsAppFacebook

Unirse a la lista de alertas

Reciba alertas por correo electrónico cuando se publiquen retiros críticos.

Support The Recall File

Help keep official recall alerts free, accessible, and fast for everyone.

Donate with PayPal

Supports USD, EUR, GBP, International Cards & PayPal

Spread the WordJAMP Digoxin tablets: One lot recalled due to possible oversized tablets which may pose overdose risk

Install The Recall File App

Check safety warnings, scan your pantry, and monitor your vehicles directly from your home screen.